Saturday | 30 August, 2008
Stories about: GBM
- +
Big week for Australian biotechs part II 13/03/2008 12:18:34
Cytopia goes into Phase II trials for vascular disrupting agent while Benitec licensee agrees to develop RNAi-based therapy for hepatitis C.
Additional Resources
Newsletter Subscription
Australian Life Scientist Member Login
Beyond The Hybrid TV Card Norm 2008-08-26 15:29:00+10
Go Green with Kingston - Save the PCB, Save the World 2008-08-25 16:10:00+10
VIA Pico-ITX at the Heart of Modern Robots 2008-08-25 13:50:00+10
Fujitsu unveils winning formula for success with Intel® Centrino® 2 processor technology. 2008-08-25 12:42:00+10
Multimedia Technology & Herma Technologies announce new audience feedback solution from REPLY Systems. 2008-08-19 11:05:00+10
Sponsored Links
Subscribe to Australian Life Scientist
Australian Life Scientist is Australia's leading magazine for the life sciences sector. ALS is available free of charge to qualified persons working in the life sciences - register now for your free subscription.
